Healthcare-associated methicillin-resistant Staph aureus (MRSA) control in Australia and New Zealand-2007 Australasian Society for Infectious Diseases (ASID) Conference forum convened by Healthcare Infection Control Special Interest Group (HICSIG)

2007 ◽  
Vol 12 (2) ◽  
pp. 60-66 ◽  
Author(s):  
John Ferguson
Keyword(s):  
New Zealand ◽  
Infectious Diseases ◽  
Infection Control ◽  
Interest Group ◽  
Special Interest ◽  
Special Interest Group ◽  
Methicillin Resistant ◽  
Staph Aureus ◽  
Healthcare Associated

scholarly journals Staphylococcus aureus bacteraemia: The Australia New Zealand Cooperative on Outcomes in Staphylococcal Sepsis (ANZCOSS)

2008 ◽  
Vol 29 (3) ◽  
pp. 147
Author(s):  
John Turnidge ◽  
Despina Kotsanas
Keyword(s):  
Staphylococcus Aureus ◽  
Intensive Care ◽  
New Zealand ◽  
Infectious Diseases ◽  
Infection Control ◽  
Intensive Care Units ◽  
Sepsis Syndrome ◽  
Methicillin Resistant ◽  
Life Threatening ◽  
Resistant Strains

Staphylococcus aureus is such a common organism, both as a coloniser and cause of infection in humans, that it is easy to take it for granted. Microbiologists, infectious diseases specialists and infection control practitioners deal with the organism on a regular basis, from screening for methicillin-resistant strains (MRSA) in asymptomatic carriers to treating patients with life-threatening sepsis syndrome in intensive care units.

A survey of anaesthetists on uterotonic usage practices for elective caesarean section in Australia and New Zealand

2021 ◽  
pp. 0310057X2110028
Author(s):  
Nico CS Terblanche ◽  
Petr Otahal ◽  
James E Sharman
Keyword(s):  
New Zealand ◽  
Caesarean Section ◽  
Interest Group ◽  
Royal College ◽  
Special Interest ◽  
Significant Variation ◽  
Elective Caesarean Section ◽  
Special Interest Group ◽  
High Dose ◽  
Obstetric Anaesthesia

Prophylactic administration of uterotonics ensures adequate uterine contraction at elective caesarean section to prevent substantial haemorrhage. Royal College of Obstetricians and Gynaecologists guidelines advise the administration of oxytocin 5 IU as a ‘slow bolus’ but there are variations in clinical practice. This study aimed to determine the beliefs and uterotonic usage practices at elective caesarean section by surveying anaesthetist members of the Obstetric Anaesthesia Special Interest Group in Australia and New Zealand. Questionnaires were emailed to Obstetric Anaesthesia Special Interest Group members and the response rate was 33%, with analysis of 279 completed reports. Oxytocin was the most commonly used first-line uterotonic, but extensive variation in oxytocin bolus use was identified. Thirty-eight percent of anaesthetists routinely administered Royal College of Obstetricians and Gynaecologists guideline–recommended 5 IU, whereas 38% favoured low dose (<5 IU), 10% high dose (≥10 IU) oxytocin, and 13% carbetocin (100 µg). More than 50% felt the evidence was weak for guideline-recommended 5 IU. Wide variation in the duration of oxytocin administration was also identified. Fifty-eight percent of anaesthetists routinely gave follow-up oxytocin infusions, most commonly at 40 IU over four hours, but there was significant variation in the dosage (10–40 IU) and administration duration (one hour to ≥six hours). In conclusion, there is significant variation in oxytocin usage practices at elective caesarean section among Australian and New Zealand anaesthetists. This variation may be due to a lack of strong evidence to guide practice. This emphasises the need for high quality trials in this clinically important area.

Special Interest Group 13 (Swallowing and Swallowing Disorders)

ASHA Leader ◽  
2012 ◽  
Vol 17 (5) ◽  
Author(s):  
Debra Suiter ◽  
Laurie Sterling ◽  
Lynne Brady Wagner
Keyword(s):  
Interest Group ◽  
Special Interest ◽  
Swallowing Disorders ◽  
Special Interest Group ◽  
Group 13
Sign in / Sign up

Export Citation Format

Share Document